Bio-thera Solutions, Ltd. Class ASSE: 688177

"Bio-Thera Solutions, Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

Aug 26, 2026 · Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange

Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Bio-thera Solutions, Ltd. Class A

"Bio-Thera Solutions, Ltd."Announcement on Voluntary Disclosure of the Receipt of the Approval Notice for Supplementary Application for Bevacizumab Injection (POBEVCY)Aug 21
"Bio-Thera Solutions, Ltd."Announcement on Voluntary Disclosure Regarding the Progress of Receipt of Milestone Payment under the License and Commercialization Agreement with Intas Pharmaceuticals Ltd. for BAT2506 (Golimumab) InjectionJul 30
"Bio-Thera Solutions, Ltd."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026Jul 29
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8013, an Antibody Drug Conjugate Targeting CD25 for the Treatment of Advanced Solid TumorsJul 23

All Bio-thera Solutions, Ltd. Class A news releases